Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 19,563 | 18,940 | 10,323 | 12,459 | 18,141 |
| Operating Income | -19,563 | -18,940 | -10,323 | -12,459 | -18,141 |
| Interest Expense | -405 | 3,084 | 0 | 270 | 0 |
| Other Income | 63,567 | -92,262 | -855 | -262 | -2,533 |
| Pre-tax Income | 44,409 | -114,286 | -11,178 | -12,991 | -20,675 |
| Income Tax | N/A | 3 | N/A | N/A | N/A |
| Net Income Continuous | 44,409 | -114,289 | -11,178 | -12,991 | -20,675 |
| Net Income | $44,409 | $-114,289 | $-11,178 | $-12,991 | $-20,675 |
| EPS Basic Total Ops | 1.91 | -8.01 | -0.86 | -0.99 | -1.61 |
| EPS Basic Continuous Ops | 1.91 | -8.01 | -0.86 | -0.95 | -1.61 |
| EPS Diluted Total Ops | -0.89 | -8.01 | -0.86 | -0.99 | -1.61 |
| EPS Diluted Continuous Ops | 1.74 | -8.01 | -0.86 | -0.95 | -1.61 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -1.55 | -0.80 | N/A | N/A |
| EBITDA(a) | $-19,534 | $-18,912 | $-10,295 | $-12,448 | $-18,130 |